Roivant Sciences (ROIV) CAO logs open-market sale of 13,538 shares

Rhea-AI Filing Summary

Roivant Sciences Ltd. Chief Accounting Officer Jennifer Humes reported an open-market sale of 13,538 Common Shares of Roivant Sciences on April 8, 2026. The weighted average sale price was $28.37 per share, with individual trades executed between $28.36 and $28.38. After this transaction, she directly holds 84,191 Common Shares.

Insider Trade Summary

Net Seller: 13,538 shares ($384,073)

Net Sell 1 txn

Insider Humes Jennifer

Role Chief Accounting Officer

Sold 13,538 shs ($384K)

Type	Security	Shares	Price	Value
Sale	Common Shares	13,538	$28.37	$384K

Holdings After Transaction: Common Shares — 84,191 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 13,538 shares Weighted average sale price: $28.37 per share Sale price range: $28.36–$28.38 per share +1 more

4 metrics

Shares sold 13,538 shares Open-market sale of Common Shares on April 8, 2026

Weighted average sale price $28.37 per share Average price for 13,538 Common Shares sold

Sale price range $28.36–$28.38 per share Range of individual trade prices in the sale

Shares held after transaction 84,191 shares Direct ownership of Common Shares after the sale

Key Terms

open-market sale, weighted average price, Common Shares, Form 4, +1 more

5 terms

open-market sale financial

"transaction_action: "open-market sale" for the Common Shares transaction"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Shares financial

"These shares were sold in multiple transactions at prices ranging from $28.36 to $28.38."

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Form 4 regulatory

"INSIDER FILING DATA (Form 4) describes this insider transaction."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Chief Accounting Officer financial

"Humes Jennifer is listed with officer_title: "Chief Accounting Officer"."

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Humes Jennifer

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/08/2026		S		13,538	D	$28.37(1)	84,191	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.36 to $28.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

	By: /s/ Jo Chen, as Attorney-in-Fact for Jennifer Humes	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ROIV executive Jennifer Humes report?

Jennifer Humes reported an open-market sale of 13,538 Roivant Sciences Common Shares. The transaction took place on April 8, 2026 at a weighted average price of $28.37 per share, as disclosed in the Form 4 filing.

At what price did Jennifer Humes sell Roivant Sciences (ROIV) shares?

The reported weighted average sale price was $28.37 per Roivant Sciences Common Share. According to the filing, individual trades occurred in a narrow range between $28.36 and $28.38, reflecting multiple executions aggregated into this reported average.

How many Roivant Sciences shares does Jennifer Humes hold after this Form 4 sale?

After selling 13,538 Common Shares, Jennifer Humes directly holds 84,191 Roivant Sciences Common Shares. This post-transaction holding figure comes directly from the Form 4 and reflects her remaining direct ownership position following the reported sale.

What does an open-market sale by a Roivant Sciences officer mean for investors?

An open-market sale means the officer sold shares on the public market at prevailing prices. The Form 4 shows only that 13,538 shares were sold at about $28.37; it does not explain her reasons, so investors typically view this as routine personal portfolio activity.

Did the Roivant Sciences Form 4 specify if sales were at a single price?

No, the filing specifies that the reported price is a weighted average. The footnote explains that the 13,538 shares were sold in multiple transactions, with individual prices ranging from $28.36 to $28.38 per share, all on the same trade date.